The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis
Abstract
Objective. The effect of chimeric anti–tumor necrosis factor α (TNFα) monoclonal antibody (MAb) therapy on synovial inflammation was studied in order to address the hypothesis that anti‐TNFα therapy leads to down‐regulation of adhesion molecules and a decrease in inflammatory cell influx in synovial tissue (ST). Methods. The immunohistologic features of synovial biopsy specimens, both before and 4 weeks after anti‐TNFα MAb (cA2) therapy, were studied in 14 patients with rheumatoid arthritis (RA). The patients either received a placebo (n = 2), or were given intravenous doses of cA2 at 10 mg/kg (n = 5) or 20 mg/kg (n = 7). Results. A significant (P < 0.03) reduction in the mean scores for T cells and for the adhesion molecules, vascular cell adhesion molecule 1 and E‐selectin, was observed after therapy with 10 mg/kg or 20 mg/kg of cA2 in RA patients. Conclusion. The reduced expression of adhesion molecules, and the decrease in cellularity of rheumatoid ST after cA2 administration support the hypothesis the antiinflammatory effect of anti‐TNFα therapy might be partly explained by down‐regulation of cytokine‐inducible vascular adhesion molecules in ST, with a consequent reduction of cell traffic into joints.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682
Self-citationBRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
Elliott, M. J., Maini, R. N., Feldmann, M., Long‐Fox, A., Charles, P., Katsikis, P., Brennan, F. M., Walker, J., Bijl, H., Ghrayeb, J., et al. (1993) · Arthritis & Rheumatism · doi:10.1002/art.1780361206 · Cited by 1,038
Self-citationPhilip, R., & Epstein, L. B. (1986) · Nature · doi:10.1038/323086a0 · Cited by 767
Nawroth, P. P., Bank, I., Handley, D., Cassimeris, J., Chess, L., & Stern, D. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1363 · Cited by 693
Van Damme, J., Opdenakker, G., Simpson, R. J., Rubira, M. R., Cayphas, S., Vink, A., Billiau, A., & Van Snick, J. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.3.914 · Cited by 669
TNFα—A PIVOTAL ROLE IN RHEUMATOID ARTHRITIS?
BRENNAN, F. M., MAINI, R. N., & FELDMANN, M. (1992) · Rheumatology · doi:10.1093/rheumatology/31.5.293 · Cited by 386
Self-citationHaworth, C., Brennan, F. M., Chantry, D., Turner, M., Maini, R. N., & Feldmann, M. (1991) · European Journal of Immunology · doi:10.1002/eji.1830211039 · Cited by 299
Self-citationPaulus, H. E., Egger, M. J., Ward, J. R., & James Williams, H. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330403 · Cited by 285
Paleolog, E. M., Hunt, M., Elliott, M. J., Feldmann, M., Maini, R. N., & Woody, J. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390703 · Cited by 240
Self-citationVan Der Lubbe, P. A., Dijkmans, B. A. C., Markusse, H. M., Nässander, U., & Breedveld, F. C. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380812 · Cited by 195
Self-citationTak, P. P., Van Der Lubbe, P. A., Cauli, A., Daha, M. R., Smeets, T. J. M., Kluin, P. M., Meinders, A. E., Yanni, G., Panayi, G. S., & Breedveld, F. C. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381012 · Cited by 193
Self-citationMonoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease
MAINI, R. N., ELLIOTT, M. J., BRENNAN, E. M., WILLIAMS, R. O., CHU, C. Q., PALEOLOG, E., CHARLES, P. J., TAYLOR, P. C., & FELDMANN, M. (1995) · Immunological Reviews · doi:10.1111/j.1600-065x.1995.tb00070.x · Cited by 181
Self-citationExpression of Adhesion Molecules in Early Rheumatoid Synovial Tissue
Tak, P. P., Thurkow, E. W., Daha, M. R., Kluin, P. M., Smeets, T. J. M., Meinders, A. E., & Breedveld, F. C. (1995) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1995.1149 · Cited by 129
Self-citationIssekutz, A. C., Meager, A., Otterness, I. G., & Issekutz, T. B. (1994) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06574.x · Cited by 71
Cited by
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Choy, E. H. S., & Panayi, G. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441207 · Cited by 2,249
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
Bathon, J. M., Martin, R. W., Fleischmann, R. M., Tesser, J. R., Schiff, M. H., Keystone, E. C., Genovese, M. C., Wasko, M. C., Moreland, L. W., Weaver, A. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432201 · Cited by 1,730
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Self-citationPathogenetic insights from the treatment of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31472-1 · Cited by 1,345
Anti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
Self-citation
Metadata
- Authors
- Tak, P. P., Taylor, P. C., Breedveld, F. C., Smeets, T. J. M., Daha, M. R., Kluin, P. M., Meinders, A. E., & Maini, R. N.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1996-07
- Volume
- 39
- Issue
- 7
- Pages
- 1077-1081
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2091651459
- Cited by
- 377
- References
- 16
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.